nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—SCN2A—migraine	0.264	1	CbGaD
Lidocaine—rheumatoid arthritis—Amitriptyline—migraine	0.201	0.608	CpDpCtD
Lidocaine—rheumatoid arthritis—Gabapentin—migraine	0.129	0.392	CpDpCtD
Lidocaine—CYP2C18—Valproic Acid—migraine	0.0239	0.081	CbGbCtD
Lidocaine—CYP2C18—Verapamil—migraine	0.0208	0.0705	CbGbCtD
Lidocaine—SCN5A—Topiramate—migraine	0.0173	0.0585	CbGbCtD
Lidocaine—SCN5A—Verapamil—migraine	0.0167	0.0564	CbGbCtD
Lidocaine—SLC22A5—Valproic Acid—migraine	0.0153	0.0518	CbGbCtD
Lidocaine—SLC22A5—Verapamil—migraine	0.0133	0.0451	CbGbCtD
Lidocaine—CYP2A6—Valproic Acid—migraine	0.0116	0.0394	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Propranolol—migraine	0.0101	0.0341	CbGbCtD
Lidocaine—CYP3A7—Propranolol—migraine	0.0101	0.0341	CbGbCtD
Lidocaine—CYP2B6—Amitriptyline—migraine	0.0083	0.0281	CbGbCtD
Lidocaine—CYP2B6—Valproic Acid—migraine	0.00757	0.0256	CbGbCtD
Lidocaine—CYP3A5—Propranolol—migraine	0.00756	0.0256	CbGbCtD
Lidocaine—CYP3A7—Verapamil—migraine	0.00692	0.0234	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Verapamil—migraine	0.00692	0.0234	CbGbCtD
Lidocaine—CYP2B6—Verapamil—migraine	0.00659	0.0223	CbGbCtD
Lidocaine—CYP3A5—Amitriptyline—migraine	0.00654	0.0221	CbGbCtD
Lidocaine—CYP2C8—Amitriptyline—migraine	0.00629	0.0213	CbGbCtD
Lidocaine—CYP3A5—Valproic Acid—migraine	0.00596	0.0202	CbGbCtD
Lidocaine—CYP2C8—Valproic Acid—migraine	0.00573	0.0194	CbGbCtD
Lidocaine—CYP1A2—Propranolol—migraine	0.00563	0.0191	CbGbCtD
Lidocaine—ABCB1—Timolol—migraine	0.00552	0.0187	CbGbCtD
Lidocaine—CYP2D6—Timolol—migraine	0.0052	0.0176	CbGbCtD
Lidocaine—CYP3A5—Verapamil—migraine	0.00519	0.0176	CbGbCtD
Lidocaine—CYP2C8—Verapamil—migraine	0.00499	0.0169	CbGbCtD
Lidocaine—ABCB1—Propranolol—migraine	0.00492	0.0167	CbGbCtD
Lidocaine—CYP1A2—Amitriptyline—migraine	0.00487	0.0165	CbGbCtD
Lidocaine—CYP2D6—Propranolol—migraine	0.00464	0.0157	CbGbCtD
Lidocaine—CYP1A2—Valproic Acid—migraine	0.00444	0.015	CbGbCtD
Lidocaine—CYP2C9—Amitriptyline—migraine	0.00438	0.0149	CbGbCtD
Lidocaine—ABCB1—Amitriptyline—migraine	0.00426	0.0144	CbGbCtD
Lidocaine—CYP2D6—Amitriptyline—migraine	0.00401	0.0136	CbGbCtD
Lidocaine—CYP2C9—Valproic Acid—migraine	0.004	0.0135	CbGbCtD
Lidocaine—CYP1A2—Verapamil—migraine	0.00386	0.0131	CbGbCtD
Lidocaine—CYP2C9—Verapamil—migraine	0.00348	0.0118	CbGbCtD
Lidocaine—ABCB1—Verapamil—migraine	0.00338	0.0114	CbGbCtD
Lidocaine—SCN3A—spinal nerve—migraine	0.00325	0.273	CbGeAlD
Lidocaine—CYP2D6—Verapamil—migraine	0.00318	0.0108	CbGbCtD
Lidocaine—CYP3A4—Propranolol—migraine	0.00295	0.00999	CbGbCtD
Lidocaine—CYP3A4—Amitriptyline—migraine	0.00255	0.00864	CbGbCtD
Lidocaine—CYP3A4—Valproic Acid—migraine	0.00232	0.00787	CbGbCtD
Lidocaine—CYP3A4—Topiramate—migraine	0.0021	0.0071	CbGbCtD
Lidocaine—CYP3A4—Verapamil—migraine	0.00202	0.00685	CbGbCtD
Lidocaine—SCN9A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00141	0.0515	CbGpPWpGaD
Lidocaine—SCN3A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00135	0.0493	CbGpPWpGaD
Lidocaine—SCN4A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.0013	0.0474	CbGpPWpGaD
Lidocaine—SCN2A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.0013	0.0474	CbGpPWpGaD
Lidocaine—SCN10A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.00125	0.0457	CbGpPWpGaD
Lidocaine—SCN9A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.0012	0.0438	CbGpPWpGaD
Lidocaine—SCN3A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00115	0.0419	CbGpPWpGaD
Lidocaine—SCN4A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.0011	0.0403	CbGpPWpGaD
Lidocaine—SCN10A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.00107	0.0388	CbGpPWpGaD
Lidocaine—Etidocaine—SCN2A—migraine	0.00103	0.279	CrCbGaD
Lidocaine—SCN5A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000881	0.0321	CbGpPWpGaD
Lidocaine—SCN10A—peripheral nervous system—migraine	0.000881	0.0739	CbGeAlD
Lidocaine—SCN5A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000749	0.0273	CbGpPWpGaD
Lidocaine—SCN10A—nerve—migraine	0.000687	0.0576	CbGeAlD
Lidocaine—EGFR—EGFR-dependent Endothelin signaling events—EDNRA—migraine	0.000559	0.0204	CbGpPWpGaD
Lidocaine—SCN9A—L1CAM interactions—SCN1A—migraine	0.000543	0.0198	CbGpPWpGaD
Lidocaine—SCN3A—L1CAM interactions—SCN1A—migraine	0.000519	0.0189	CbGpPWpGaD
Lidocaine—SCN4A—L1CAM interactions—SCN1A—migraine	0.000499	0.0182	CbGpPWpGaD
Lidocaine—SCN2A—L1CAM interactions—SCN1A—migraine	0.000499	0.0182	CbGpPWpGaD
Lidocaine—SCN10A—L1CAM interactions—SCN1A—migraine	0.000481	0.0175	CbGpPWpGaD
Lidocaine—SCN9A—L1CAM interactions—SCN2A—migraine	0.000461	0.0168	CbGpPWpGaD
Lidocaine—SCN3A—L1CAM interactions—SCN2A—migraine	0.000441	0.0161	CbGpPWpGaD
Lidocaine—SCN9A—trigeminal ganglion—migraine	0.000437	0.0367	CbGeAlD
Lidocaine—SCN4A—L1CAM interactions—SCN2A—migraine	0.000424	0.0155	CbGpPWpGaD
Lidocaine—Mepivacaine—SCN1A—migraine	0.000414	0.112	CrCbGaD
Lidocaine—SCN10A—L1CAM interactions—SCN2A—migraine	0.000409	0.0149	CbGpPWpGaD
Lidocaine—Mepivacaine—SCN2A—migraine	0.000365	0.0992	CrCbGaD
Lidocaine—SCN5A—L1CAM interactions—SCN1A—migraine	0.000338	0.0123	CbGpPWpGaD
Lidocaine—SCN10A—trigeminal ganglion—migraine	0.000333	0.028	CbGeAlD
Lidocaine—Ropivacaine—SCN1A—migraine	0.000327	0.0889	CrCbGaD
Lidocaine—Chloroprocaine—HTR3A—migraine	0.000322	0.0874	CrCbGaD
Lidocaine—Tocainide—SCN1A—migraine	0.000307	0.0836	CrCbGaD
Lidocaine—SCN2A—brainstem—migraine	0.000306	0.0257	CbGeAlD
Lidocaine—Ropivacaine—SCN2A—migraine	0.000288	0.0784	CrCbGaD
Lidocaine—SCN5A—L1CAM interactions—SCN2A—migraine	0.000287	0.0105	CbGpPWpGaD
Lidocaine—Tocainide—SCN2A—migraine	0.000271	0.0737	CrCbGaD
Lidocaine—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—LRP1—migraine	0.000243	0.00887	CbGpPWpGaD
Lidocaine—EGFR—cerebellum—migraine	0.000232	0.0195	CbGeAlD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000229	0.00835	CbGpPWpGaD
Lidocaine—EGFR—L1CAM interactions—SCN1A—migraine	0.000221	0.00807	CbGpPWpGaD
Lidocaine—SCN5A—cardiovascular system—migraine	0.000219	0.0183	CbGeAlD
Lidocaine—SCN9A—Axon guidance—SCN1A—migraine	0.000205	0.00747	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—SCN1A—migraine	0.000196	0.00715	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	0.000195	0.0071	CbGpPWpGaD
Lidocaine—SCN4A—head—migraine	0.000191	0.016	CbGeAlD
Lidocaine—Procainamide—SCN1A—migraine	0.00019	0.0516	CrCbGaD
Lidocaine—SCN4A—Axon guidance—SCN1A—migraine	0.000188	0.00687	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—SCN1A—migraine	0.000188	0.00687	CbGpPWpGaD
Lidocaine—EGFR—brain—migraine	0.000188	0.0158	CbGeAlD
Lidocaine—EGFR—L1CAM interactions—SCN2A—migraine	0.000188	0.00686	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—SCN1A—migraine	0.000182	0.00662	CbGpPWpGaD
Lidocaine—SCN4A—nervous system—migraine	0.000181	0.0152	CbGeAlD
Lidocaine—SLC22A5—trigeminal ganglion—migraine	0.000176	0.0148	CbGeAlD
Lidocaine—SCN9A—Axon guidance—SCN2A—migraine	0.000174	0.00635	CbGpPWpGaD
Lidocaine—SCN4A—central nervous system—migraine	0.000174	0.0146	CbGeAlD
Lidocaine—SCN2A—head—migraine	0.000169	0.0142	CbGeAlD
Lidocaine—Procainamide—SCN2A—migraine	0.000168	0.0455	CrCbGaD
Lidocaine—SCN3A—Axon guidance—SCN2A—migraine	0.000167	0.00608	CbGpPWpGaD
Lidocaine—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.000165	0.00602	CbGpPWpGaD
Lidocaine—SCN10A—head—migraine	0.000163	0.0137	CbGeAlD
Lidocaine—SCN4A—Axon guidance—SCN2A—migraine	0.00016	0.00584	CbGpPWpGaD
Lidocaine—SCN2A—nervous system—migraine	0.00016	0.0134	CbGeAlD
Lidocaine—SCN9A—brain—migraine	0.000155	0.013	CbGeAlD
Lidocaine—SCN10A—Axon guidance—SCN2A—migraine	0.000155	0.00563	CbGpPWpGaD
Lidocaine—SCN10A—nervous system—migraine	0.000154	0.013	CbGeAlD
Lidocaine—SCN2A—central nervous system—migraine	0.000154	0.0129	CbGeAlD
Lidocaine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—migraine	0.000151	0.0055	CbGpPWpGaD
Lidocaine—SCN2A—cerebellum—migraine	0.000151	0.0126	CbGeAlD
Lidocaine—SCN10A—central nervous system—migraine	0.000149	0.0125	CbGeAlD
Lidocaine—SCN3A—head—migraine	0.000148	0.0125	CbGeAlD
Lidocaine—SCN5A—head—migraine	0.000148	0.0124	CbGeAlD
Lidocaine—Urinary retention—Gabapentin—migraine	0.000147	0.00219	CcSEcCtD
Lidocaine—Cardiac arrest—Gabapentin—migraine	0.000147	0.00219	CcSEcCtD
Lidocaine—SCN9A—Developmental Biology—SCN1A—migraine	0.000146	0.00533	CbGpPWpGaD
Lidocaine—Agitation—Verapamil—migraine	0.000146	0.00217	CcSEcCtD
Lidocaine—Disorientation—Topiramate—migraine	0.000146	0.00217	CcSEcCtD
Lidocaine—Angioedema—Verapamil—migraine	0.000145	0.00216	CcSEcCtD
Lidocaine—Drowsiness—Valproic Acid—migraine	0.000144	0.00214	CcSEcCtD
Lidocaine—Asthma—Timolol—migraine	0.000144	0.00214	CcSEcCtD
Lidocaine—Feeling abnormal—Amitriptyline—migraine	0.000142	0.00212	CcSEcCtD
Lidocaine—Bronchospasm—Timolol—migraine	0.000141	0.00211	CcSEcCtD
Lidocaine—Anaphylactic shock—Propranolol—migraine	0.000141	0.0021	CcSEcCtD
Lidocaine—SCN3A—nervous system—migraine	0.000141	0.0118	CbGeAlD
Lidocaine—Stomatitis—Valproic Acid—migraine	0.00014	0.00209	CcSEcCtD
Lidocaine—SCN5A—nervous system—migraine	0.00014	0.0118	CbGeAlD
Lidocaine—SCN3A—Developmental Biology—SCN1A—migraine	0.00014	0.0051	CbGpPWpGaD
Lidocaine—Loss of consciousness—Verapamil—migraine	0.000139	0.00208	CcSEcCtD
Lidocaine—SCN4A—brain—migraine	0.000138	0.0116	CbGeAlD
Lidocaine—Nervous system disorder—Propranolol—migraine	0.000138	0.00206	CcSEcCtD
Lidocaine—Visual disturbance—Topiramate—migraine	0.000137	0.00205	CcSEcCtD
Lidocaine—Convulsion—Verapamil—migraine	0.000137	0.00205	CcSEcCtD
Lidocaine—Urticaria—Amitriptyline—migraine	0.000137	0.00205	CcSEcCtD
Lidocaine—Hypertension—Verapamil—migraine	0.000137	0.00204	CcSEcCtD
Lidocaine—SCN3A—central nervous system—migraine	0.000136	0.0114	CbGeAlD
Lidocaine—SCN5A—central nervous system—migraine	0.000135	0.0113	CbGeAlD
Lidocaine—Chest pain—Verapamil—migraine	0.000135	0.00201	CcSEcCtD
Lidocaine—SCN2A—Developmental Biology—SCN1A—migraine	0.000134	0.0049	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—SCN1A—migraine	0.000134	0.0049	CbGpPWpGaD
Lidocaine—Dysphagia—Gabapentin—migraine	0.000134	0.00199	CcSEcCtD
Lidocaine—Asthma—Gabapentin—migraine	0.000134	0.00199	CcSEcCtD
Lidocaine—SCN3A—cerebellum—migraine	0.000132	0.0111	CbGeAlD
Lidocaine—CYP2A6—cerebellum—migraine	0.000132	0.0111	CbGeAlD
Lidocaine—ABCB1—blood vessel—migraine	0.000132	0.0111	CbGeAlD
Lidocaine—Bronchospasm—Gabapentin—migraine	0.000132	0.00196	CcSEcCtD
Lidocaine—Bradycardia—Valproic Acid—migraine	0.000132	0.00196	CcSEcCtD
Lidocaine—Confusional state—Verapamil—migraine	0.000131	0.00194	CcSEcCtD
Lidocaine—Sweating increased—Gabapentin—migraine	0.00013	0.00194	CcSEcCtD
Lidocaine—Diplopia—Topiramate—migraine	0.00013	0.00194	CcSEcCtD
Lidocaine—Osteoarthritis—Topiramate—migraine	0.00013	0.00194	CcSEcCtD
Lidocaine—Haemoglobin—Valproic Acid—migraine	0.00013	0.00193	CcSEcCtD
Lidocaine—SCN10A—Developmental Biology—SCN1A—migraine	0.00013	0.00473	CbGpPWpGaD
Lidocaine—Rhinitis—Valproic Acid—migraine	0.00013	0.00193	CcSEcCtD
Lidocaine—Anaphylactic shock—Verapamil—migraine	0.00013	0.00193	CcSEcCtD
Lidocaine—Oedema—Verapamil—migraine	0.00013	0.00193	CcSEcCtD
Lidocaine—Haemorrhage—Valproic Acid—migraine	0.000129	0.00192	CcSEcCtD
Lidocaine—Hypoaesthesia—Valproic Acid—migraine	0.000129	0.00192	CcSEcCtD
Lidocaine—SCN5A—Axon guidance—SCN1A—migraine	0.000128	0.00466	CbGpPWpGaD
Lidocaine—Shock—Verapamil—migraine	0.000127	0.0019	CcSEcCtD
Lidocaine—Psychotic disorder—Topiramate—migraine	0.000127	0.0019	CcSEcCtD
Lidocaine—Paraesthesia—Propranolol—migraine	0.000126	0.00188	CcSEcCtD
Lidocaine—Dyspnoea—Propranolol—migraine	0.000126	0.00187	CcSEcCtD
Lidocaine—Hyperhidrosis—Verapamil—migraine	0.000125	0.00186	CcSEcCtD
Lidocaine—Somnolence—Propranolol—migraine	0.000125	0.00186	CcSEcCtD
Lidocaine—Visual impairment—Valproic Acid—migraine	0.000125	0.00185	CcSEcCtD
Lidocaine—SCN9A—Developmental Biology—SCN2A—migraine	0.000124	0.00453	CbGpPWpGaD
Lidocaine—Asthenia—Amitriptyline—migraine	0.000124	0.00185	CcSEcCtD
Lidocaine—Urinary retention—Topiramate—migraine	0.000124	0.00185	CcSEcCtD
Lidocaine—SCN2A—brain—migraine	0.000122	0.0103	CbGeAlD
Lidocaine—CYP2C18—FOXA1 transcription factor network—ESR1—migraine	0.000122	0.00445	CbGpPWpGaD
Lidocaine—Gastrointestinal disorder—Propranolol—migraine	0.000122	0.00181	CcSEcCtD
Lidocaine—Hypotension—Verapamil—migraine	0.000121	0.0018	CcSEcCtD
Lidocaine—Eye disorder—Valproic Acid—migraine	0.000121	0.0018	CcSEcCtD
Lidocaine—Tinnitus—Valproic Acid—migraine	0.000121	0.00179	CcSEcCtD
Lidocaine—Pain—Propranolol—migraine	0.00012	0.00179	CcSEcCtD
Lidocaine—Drowsiness—Gabapentin—migraine	0.000119	0.00178	CcSEcCtD
Lidocaine—SCN3A—Developmental Biology—SCN2A—migraine	0.000119	0.00434	CbGpPWpGaD
Lidocaine—SCN10A—brain—migraine	0.000118	0.00991	CbGeAlD
Lidocaine—Angiopathy—Valproic Acid—migraine	0.000117	0.00175	CcSEcCtD
Lidocaine—Bradycardia—Timolol—migraine	0.000117	0.00174	CcSEcCtD
Lidocaine—Neuropathy peripheral—Gabapentin—migraine	0.000117	0.00174	CcSEcCtD
Lidocaine—Immune system disorder—Valproic Acid—migraine	0.000117	0.00174	CcSEcCtD
Lidocaine—Stomatitis—Gabapentin—migraine	0.000116	0.00173	CcSEcCtD
Lidocaine—Paraesthesia—Verapamil—migraine	0.000116	0.00173	CcSEcCtD
Lidocaine—Chills—Valproic Acid—migraine	0.000116	0.00173	CcSEcCtD
Lidocaine—Dyspnoea—Verapamil—migraine	0.000115	0.00172	CcSEcCtD
Lidocaine—Rhinitis—Timolol—migraine	0.000115	0.00172	CcSEcCtD
Lidocaine—Somnolence—Verapamil—migraine	0.000115	0.00171	CcSEcCtD
Lidocaine—SCN4A—Developmental Biology—SCN2A—migraine	0.000114	0.00417	CbGpPWpGaD
Lidocaine—Dizziness—Amitriptyline—migraine	0.000114	0.0017	CcSEcCtD
Lidocaine—SCN9A—Developmental Biology—MEF2D—migraine	0.000114	0.00415	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000113	0.00413	CbGpPWpGaD
Lidocaine—Dysphagia—Topiramate—migraine	0.000113	0.00168	CcSEcCtD
Lidocaine—Asthma—Topiramate—migraine	0.000113	0.00168	CcSEcCtD
Lidocaine—Urticaria—Propranolol—migraine	0.000112	0.00167	CcSEcCtD
Lidocaine—Visual impairment—Timolol—migraine	0.000111	0.00165	CcSEcCtD
Lidocaine—Pain—Verapamil—migraine	0.000111	0.00165	CcSEcCtD
Lidocaine—Tension—Valproic Acid—migraine	0.00011	0.00164	CcSEcCtD
Lidocaine—CYP2B6—cardiovascular system—migraine	0.00011	0.00926	CbGeAlD
Lidocaine—SCN10A—Developmental Biology—SCN2A—migraine	0.00011	0.00402	CbGpPWpGaD
Lidocaine—CYP2C18—FOXA1 transcription factor network—FOS—migraine	0.00011	0.00401	CbGpPWpGaD
Lidocaine—Dysgeusia—Valproic Acid—migraine	0.00011	0.00164	CcSEcCtD
Lidocaine—Vomiting—Amitriptyline—migraine	0.00011	0.00164	CcSEcCtD
Lidocaine—Sweating increased—Topiramate—migraine	0.00011	0.00163	CcSEcCtD
Lidocaine—Nervousness—Valproic Acid—migraine	0.000109	0.00163	CcSEcCtD
Lidocaine—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—migraine	0.000109	0.00398	CbGpPWpGaD
Lidocaine—CYP2C9—cardiovascular system—migraine	0.000109	0.00917	CbGeAlD
Lidocaine—Bradycardia—Gabapentin—migraine	0.000109	0.00162	CcSEcCtD
Lidocaine—Rash—Amitriptyline—migraine	0.000109	0.00162	CcSEcCtD
Lidocaine—Dermatitis—Amitriptyline—migraine	0.000109	0.00162	CcSEcCtD
Lidocaine—SCN3A—Developmental Biology—MEF2D—migraine	0.000109	0.00397	CbGpPWpGaD
Lidocaine—Back pain—Valproic Acid—migraine	0.000109	0.00162	CcSEcCtD
Lidocaine—SCN5A—Axon guidance—SCN2A—migraine	0.000109	0.00396	CbGpPWpGaD
Lidocaine—Headache—Amitriptyline—migraine	0.000108	0.00161	CcSEcCtD
Lidocaine—SCN3A—brain—migraine	0.000108	0.00903	CbGeAlD
Lidocaine—Eye disorder—Timolol—migraine	0.000108	0.0016	CcSEcCtD
Lidocaine—CYP2A6—brain—migraine	0.000107	0.00902	CbGeAlD
Lidocaine—Rhinitis—Gabapentin—migraine	0.000107	0.0016	CcSEcCtD
Lidocaine—Tinnitus—Timolol—migraine	0.000107	0.0016	CcSEcCtD
Lidocaine—SCN5A—brain—migraine	0.000107	0.009	CbGeAlD
Lidocaine—Haemorrhage—Gabapentin—migraine	0.000107	0.0016	CcSEcCtD
Lidocaine—Cardiac disorder—Timolol—migraine	0.000107	0.00159	CcSEcCtD
Lidocaine—Feeling abnormal—Verapamil—migraine	0.000107	0.00159	CcSEcCtD
Lidocaine—Hypoaesthesia—Gabapentin—migraine	0.000107	0.00159	CcSEcCtD
Lidocaine—Vision blurred—Valproic Acid—migraine	0.000106	0.00158	CcSEcCtD
Lidocaine—CYP2A6—Fluoropyrimidine Activity—MTHFR—migraine	0.000106	0.00384	CbGpPWpGaD
Lidocaine—Tremor—Valproic Acid—migraine	0.000105	0.00157	CcSEcCtD
Lidocaine—SCN4A—Developmental Biology—MEF2D—migraine	0.000105	0.00381	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—MEF2D—migraine	0.000105	0.00381	CbGpPWpGaD
Lidocaine—Angiopathy—Timolol—migraine	0.000104	0.00155	CcSEcCtD
Lidocaine—Immune system disorder—Timolol—migraine	0.000104	0.00155	CcSEcCtD
Lidocaine—Hypersensitivity—Propranolol—migraine	0.000104	0.00154	CcSEcCtD
Lidocaine—Agitation—Valproic Acid—migraine	0.000103	0.00154	CcSEcCtD
Lidocaine—Visual impairment—Gabapentin—migraine	0.000103	0.00154	CcSEcCtD
Lidocaine—Urticaria—Verapamil—migraine	0.000103	0.00153	CcSEcCtD
Lidocaine—Angioedema—Valproic Acid—migraine	0.000103	0.00153	CcSEcCtD
Lidocaine—Nausea—Amitriptyline—migraine	0.000103	0.00153	CcSEcCtD
Lidocaine—Asthenia—Propranolol—migraine	0.000101	0.0015	CcSEcCtD
Lidocaine—SCN10A—Developmental Biology—MEF2D—migraine	0.000101	0.00368	CbGpPWpGaD
Lidocaine—CYP2D6—brainstem—migraine	0.0001	0.00843	CbGeAlD
Lidocaine—Erythema—Timolol—migraine	0.0001	0.00149	CcSEcCtD
Lidocaine—Eye disorder—Gabapentin—migraine	0.0001	0.00149	CcSEcCtD
Lidocaine—Tinnitus—Gabapentin—migraine	9.99e-05	0.00149	CcSEcCtD
Lidocaine—Cardiac disorder—Gabapentin—migraine	9.94e-05	0.00148	CcSEcCtD
Lidocaine—Neuropathy peripheral—Topiramate—migraine	9.84e-05	0.00147	CcSEcCtD
Lidocaine—Tension—Timolol—migraine	9.83e-05	0.00146	CcSEcCtD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—TRPM8—migraine	9.82e-05	0.00358	CbGpPWpGaD
Lidocaine—Dysgeusia—Timolol—migraine	9.81e-05	0.00146	CcSEcCtD
Lidocaine—Stomatitis—Topiramate—migraine	9.79e-05	0.00146	CcSEcCtD
Lidocaine—Nervousness—Timolol—migraine	9.73e-05	0.00145	CcSEcCtD
Lidocaine—Hypertension—Valproic Acid—migraine	9.71e-05	0.00145	CcSEcCtD
Lidocaine—Immune system disorder—Gabapentin—migraine	9.68e-05	0.00144	CcSEcCtD
Lidocaine—Chills—Gabapentin—migraine	9.61e-05	0.00143	CcSEcCtD
Lidocaine—Chest pain—Valproic Acid—migraine	9.58e-05	0.00143	CcSEcCtD
Lidocaine—Anxiety—Valproic Acid—migraine	9.55e-05	0.00142	CcSEcCtD
Lidocaine—Hypersensitivity—Verapamil—migraine	9.54e-05	0.00142	CcSEcCtD
Lidocaine—Vision blurred—Timolol—migraine	9.44e-05	0.00141	CcSEcCtD
Lidocaine—EGFR—SHP2 signaling—BDNF—migraine	9.39e-05	0.00342	CbGpPWpGaD
Lidocaine—CYP1A2—Estrogen Receptor Pathway—ESR1—migraine	9.39e-05	0.00342	CbGpPWpGaD
Lidocaine—Erythema—Gabapentin—migraine	9.33e-05	0.00139	CcSEcCtD
Lidocaine—Dizziness—Propranolol—migraine	9.31e-05	0.00139	CcSEcCtD
Lidocaine—Asthenia—Verapamil—migraine	9.29e-05	0.00138	CcSEcCtD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	9.27e-05	0.00338	CbGpPWpGaD
Lidocaine—Confusional state—Valproic Acid—migraine	9.26e-05	0.00138	CcSEcCtD
Lidocaine—Oedema—Valproic Acid—migraine	9.18e-05	0.00137	CcSEcCtD
Lidocaine—Anaphylactic shock—Valproic Acid—migraine	9.18e-05	0.00137	CcSEcCtD
Lidocaine—Bradycardia—Topiramate—migraine	9.18e-05	0.00137	CcSEcCtD
Lidocaine—Tension—Gabapentin—migraine	9.15e-05	0.00136	CcSEcCtD
Lidocaine—Angioedema—Timolol—migraine	9.15e-05	0.00136	CcSEcCtD
Lidocaine—Dysgeusia—Gabapentin—migraine	9.13e-05	0.00136	CcSEcCtD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	9.13e-05	0.00333	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—SCN1A—migraine	9.12e-05	0.00332	CbGpPWpGaD
Lidocaine—Haemoglobin—Topiramate—migraine	9.06e-05	0.00135	CcSEcCtD
Lidocaine—Nervousness—Gabapentin—migraine	9.06e-05	0.00135	CcSEcCtD
Lidocaine—Rhinitis—Topiramate—migraine	9.04e-05	0.00135	CcSEcCtD
Lidocaine—Back pain—Gabapentin—migraine	9.02e-05	0.00134	CcSEcCtD
Lidocaine—Haemorrhage—Topiramate—migraine	9.01e-05	0.00134	CcSEcCtD
Lidocaine—Nervous system disorder—Valproic Acid—migraine	9e-05	0.00134	CcSEcCtD
Lidocaine—Hypoaesthesia—Topiramate—migraine	8.97e-05	0.00134	CcSEcCtD
Lidocaine—Vomiting—Propranolol—migraine	8.95e-05	0.00133	CcSEcCtD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	8.95e-05	0.00326	CbGpPWpGaD
Lidocaine—Hyperhidrosis—Valproic Acid—migraine	8.88e-05	0.00132	CcSEcCtD
Lidocaine—Rash—Propranolol—migraine	8.88e-05	0.00132	CcSEcCtD
Lidocaine—Dermatitis—Propranolol—migraine	8.87e-05	0.00132	CcSEcCtD
Lidocaine—Loss of consciousness—Timolol—migraine	8.8e-05	0.00131	CcSEcCtD
Lidocaine—Vision blurred—Gabapentin—migraine	8.79e-05	0.00131	CcSEcCtD
Lidocaine—Tremor—Gabapentin—migraine	8.74e-05	0.0013	CcSEcCtD
Lidocaine—Visual impairment—Topiramate—migraine	8.69e-05	0.00129	CcSEcCtD
Lidocaine—Hypertension—Timolol—migraine	8.65e-05	0.00129	CcSEcCtD
Lidocaine—Hypotension—Valproic Acid—migraine	8.58e-05	0.00128	CcSEcCtD
Lidocaine—Agitation—Gabapentin—migraine	8.57e-05	0.00128	CcSEcCtD
Lidocaine—Dizziness—Verapamil—migraine	8.56e-05	0.00128	CcSEcCtD
Lidocaine—Chest pain—Timolol—migraine	8.53e-05	0.00127	CcSEcCtD
Lidocaine—Angioedema—Gabapentin—migraine	8.52e-05	0.00127	CcSEcCtD
Lidocaine—Anxiety—Timolol—migraine	8.5e-05	0.00127	CcSEcCtD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor—ESR1—migraine	8.48e-05	0.00309	CbGpPWpGaD
Lidocaine—Eye disorder—Topiramate—migraine	8.42e-05	0.00125	CcSEcCtD
Lidocaine—Tinnitus—Topiramate—migraine	8.4e-05	0.00125	CcSEcCtD
Lidocaine—Cardiac disorder—Topiramate—migraine	8.37e-05	0.00125	CcSEcCtD
Lidocaine—Flushing—Topiramate—migraine	8.37e-05	0.00125	CcSEcCtD
Lidocaine—EGFR—Axon guidance—SCN1A—migraine	8.37e-05	0.00305	CbGpPWpGaD
Lidocaine—Nausea—Propranolol—migraine	8.36e-05	0.00125	CcSEcCtD
Lidocaine—Paraesthesia—Valproic Acid—migraine	8.25e-05	0.00123	CcSEcCtD
Lidocaine—Confusional state—Timolol—migraine	8.24e-05	0.00123	CcSEcCtD
Lidocaine—Vomiting—Verapamil—migraine	8.23e-05	0.00123	CcSEcCtD
Lidocaine—Loss of consciousness—Gabapentin—migraine	8.2e-05	0.00122	CcSEcCtD
Lidocaine—Dyspnoea—Valproic Acid—migraine	8.19e-05	0.00122	CcSEcCtD
Lidocaine—Angiopathy—Topiramate—migraine	8.18e-05	0.00122	CcSEcCtD
Lidocaine—Anaphylactic shock—Timolol—migraine	8.17e-05	0.00122	CcSEcCtD
Lidocaine—Oedema—Timolol—migraine	8.17e-05	0.00122	CcSEcCtD
Lidocaine—Rash—Verapamil—migraine	8.17e-05	0.00122	CcSEcCtD
Lidocaine—ABCB1—trigeminal ganglion—migraine	8.16e-05	0.00685	CbGeAlD
Lidocaine—Somnolence—Valproic Acid—migraine	8.16e-05	0.00122	CcSEcCtD
Lidocaine—Dermatitis—Verapamil—migraine	8.16e-05	0.00121	CcSEcCtD
Lidocaine—Immune system disorder—Topiramate—migraine	8.14e-05	0.00121	CcSEcCtD
Lidocaine—Headache—Verapamil—migraine	8.11e-05	0.00121	CcSEcCtD
Lidocaine—Chills—Topiramate—migraine	8.09e-05	0.0012	CcSEcCtD
Lidocaine—Convulsion—Gabapentin—migraine	8.08e-05	0.0012	CcSEcCtD
Lidocaine—Hypertension—Gabapentin—migraine	8.05e-05	0.0012	CcSEcCtD
Lidocaine—Shock—Timolol—migraine	8.04e-05	0.0012	CcSEcCtD
Lidocaine—Nervous system disorder—Timolol—migraine	8.02e-05	0.00119	CcSEcCtD
Lidocaine—Chest pain—Gabapentin—migraine	7.94e-05	0.00118	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Valproic Acid—migraine	7.93e-05	0.00118	CcSEcCtD
Lidocaine—Anxiety—Gabapentin—migraine	7.91e-05	0.00118	CcSEcCtD
Lidocaine—Hyperhidrosis—Timolol—migraine	7.9e-05	0.00118	CcSEcCtD
Lidocaine—Pain—Valproic Acid—migraine	7.85e-05	0.00117	CcSEcCtD
Lidocaine—Erythema—Topiramate—migraine	7.85e-05	0.00117	CcSEcCtD
Lidocaine—SCN5A—Developmental Biology—SCN2A—migraine	7.75e-05	0.00282	CbGpPWpGaD
Lidocaine—Tension—Topiramate—migraine	7.7e-05	0.00115	CcSEcCtD
Lidocaine—Nausea—Verapamil—migraine	7.69e-05	0.00115	CcSEcCtD
Lidocaine—Dysgeusia—Topiramate—migraine	7.68e-05	0.00114	CcSEcCtD
Lidocaine—Confusional state—Gabapentin—migraine	7.68e-05	0.00114	CcSEcCtD
Lidocaine—SLC22A5—cerebellum—migraine	7.67e-05	0.00644	CbGeAlD
Lidocaine—Hypotension—Timolol—migraine	7.64e-05	0.00114	CcSEcCtD
Lidocaine—Nervousness—Topiramate—migraine	7.62e-05	0.00114	CcSEcCtD
Lidocaine—Oedema—Gabapentin—migraine	7.61e-05	0.00113	CcSEcCtD
Lidocaine—Anaphylactic shock—Gabapentin—migraine	7.61e-05	0.00113	CcSEcCtD
Lidocaine—Back pain—Topiramate—migraine	7.59e-05	0.00113	CcSEcCtD
Lidocaine—Feeling abnormal—Valproic Acid—migraine	7.57e-05	0.00113	CcSEcCtD
Lidocaine—Shock—Gabapentin—migraine	7.49e-05	0.00112	CcSEcCtD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	7.48e-05	0.00273	CbGpPWpGaD
Lidocaine—CYP2B6—head—migraine	7.47e-05	0.00627	CbGeAlD
Lidocaine—Nervous system disorder—Gabapentin—migraine	7.46e-05	0.00111	CcSEcCtD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ATP1A2—migraine	7.44e-05	0.00271	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ATP1A3—migraine	7.44e-05	0.00271	CbGpPWpGaD
Lidocaine—Vision blurred—Topiramate—migraine	7.4e-05	0.0011	CcSEcCtD
Lidocaine—Hyperhidrosis—Gabapentin—migraine	7.36e-05	0.0011	CcSEcCtD
Lidocaine—Tremor—Topiramate—migraine	7.35e-05	0.00109	CcSEcCtD
Lidocaine—Paraesthesia—Timolol—migraine	7.34e-05	0.00109	CcSEcCtD
Lidocaine—Urticaria—Valproic Acid—migraine	7.29e-05	0.00109	CcSEcCtD
Lidocaine—Dyspnoea—Timolol—migraine	7.29e-05	0.00109	CcSEcCtD
Lidocaine—Somnolence—Timolol—migraine	7.27e-05	0.00108	CcSEcCtD
Lidocaine—Agitation—Topiramate—migraine	7.21e-05	0.00107	CcSEcCtD
Lidocaine—Hypotension—Gabapentin—migraine	7.11e-05	0.00106	CcSEcCtD
Lidocaine—EGFR—Axon guidance—SCN2A—migraine	7.11e-05	0.00259	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MEF2D—migraine	7.09e-05	0.00258	CbGpPWpGaD
Lidocaine—CYP2B6—nervous system—migraine	7.08e-05	0.00594	CbGeAlD
Lidocaine—Gastrointestinal disorder—Timolol—migraine	7.06e-05	0.00105	CcSEcCtD
Lidocaine—Pain—Timolol—migraine	6.99e-05	0.00104	CcSEcCtD
Lidocaine—Loss of consciousness—Topiramate—migraine	6.9e-05	0.00103	CcSEcCtD
Lidocaine—Paraesthesia—Gabapentin—migraine	6.84e-05	0.00102	CcSEcCtD
Lidocaine—CYP2B6—central nervous system—migraine	6.82e-05	0.00572	CbGeAlD
Lidocaine—Convulsion—Topiramate—migraine	6.8e-05	0.00101	CcSEcCtD
Lidocaine—Dyspnoea—Gabapentin—migraine	6.79e-05	0.00101	CcSEcCtD
Lidocaine—Hypertension—Topiramate—migraine	6.77e-05	0.00101	CcSEcCtD
Lidocaine—Somnolence—Gabapentin—migraine	6.77e-05	0.00101	CcSEcCtD
Lidocaine—Hypersensitivity—Valproic Acid—migraine	6.77e-05	0.00101	CcSEcCtD
Lidocaine—Feeling abnormal—Timolol—migraine	6.74e-05	0.001	CcSEcCtD
Lidocaine—Chest pain—Topiramate—migraine	6.68e-05	0.000995	CcSEcCtD
Lidocaine—Anxiety—Topiramate—migraine	6.66e-05	0.000992	CcSEcCtD
Lidocaine—Asthenia—Valproic Acid—migraine	6.59e-05	0.000981	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Gabapentin—migraine	6.57e-05	0.000979	CcSEcCtD
Lidocaine—Pain—Gabapentin—migraine	6.51e-05	0.000969	CcSEcCtD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	6.5e-05	0.00237	CbGpPWpGaD
Lidocaine—Urticaria—Timolol—migraine	6.49e-05	0.000967	CcSEcCtD
Lidocaine—Confusional state—Topiramate—migraine	6.46e-05	0.000962	CcSEcCtD
Lidocaine—Oedema—Topiramate—migraine	6.4e-05	0.000954	CcSEcCtD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—HTR3A—migraine	6.33e-05	0.00231	CbGpPWpGaD
Lidocaine—Shock—Topiramate—migraine	6.3e-05	0.000938	CcSEcCtD
Lidocaine—Nervous system disorder—Topiramate—migraine	6.28e-05	0.000935	CcSEcCtD
Lidocaine—Feeling abnormal—Gabapentin—migraine	6.27e-05	0.000934	CcSEcCtD
Lidocaine—SLC22A5—brain—migraine	6.23e-05	0.00523	CbGeAlD
Lidocaine—EGFR—Regulation of Telomerase—ESR1—migraine	6.2e-05	0.00226	CbGpPWpGaD
Lidocaine—Hyperhidrosis—Topiramate—migraine	6.19e-05	0.000922	CcSEcCtD
Lidocaine—EGFR—Signaling by ERBB4—PGR—migraine	6.1e-05	0.00222	CbGpPWpGaD
Lidocaine—Dizziness—Valproic Acid—migraine	6.07e-05	0.000904	CcSEcCtD
Lidocaine—Urticaria—Gabapentin—migraine	6.05e-05	0.000901	CcSEcCtD
Lidocaine—CYP2C8—brain—migraine	6.03e-05	0.00507	CbGeAlD
Lidocaine—Hypersensitivity—Timolol—migraine	6.02e-05	0.000897	CcSEcCtD
Lidocaine—Hypotension—Topiramate—migraine	5.98e-05	0.000891	CcSEcCtD
Lidocaine—EGFR—Developmental Biology—SCN1A—migraine	5.97e-05	0.00218	CbGpPWpGaD
Lidocaine—ABCB1—cardiovascular system—migraine	5.9e-05	0.00495	CbGeAlD
Lidocaine—EGFR—LPA receptor mediated events—FOS—migraine	5.87e-05	0.00214	CbGpPWpGaD
Lidocaine—Asthenia—Timolol—migraine	5.86e-05	0.000873	CcSEcCtD
Lidocaine—Vomiting—Valproic Acid—migraine	5.84e-05	0.00087	CcSEcCtD
Lidocaine—Rash—Valproic Acid—migraine	5.79e-05	0.000862	CcSEcCtD
Lidocaine—Dermatitis—Valproic Acid—migraine	5.78e-05	0.000861	CcSEcCtD
Lidocaine—Headache—Valproic Acid—migraine	5.75e-05	0.000857	CcSEcCtD
Lidocaine—Paraesthesia—Topiramate—migraine	5.75e-05	0.000856	CcSEcCtD
Lidocaine—Dyspnoea—Topiramate—migraine	5.71e-05	0.00085	CcSEcCtD
Lidocaine—Somnolence—Topiramate—migraine	5.69e-05	0.000848	CcSEcCtD
Lidocaine—Hypersensitivity—Gabapentin—migraine	5.61e-05	0.000835	CcSEcCtD
Lidocaine—EGFR—Regulation of Telomerase—FOS—migraine	5.59e-05	0.00204	CbGpPWpGaD
Lidocaine—CYP2D6—head—migraine	5.55e-05	0.00466	CbGeAlD
Lidocaine—Gastrointestinal disorder—Topiramate—migraine	5.53e-05	0.000823	CcSEcCtD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	5.49e-05	0.002	CbGpPWpGaD
Lidocaine—Pain—Topiramate—migraine	5.48e-05	0.000816	CcSEcCtD
Lidocaine—Asthenia—Gabapentin—migraine	5.46e-05	0.000813	CcSEcCtD
Lidocaine—Nausea—Valproic Acid—migraine	5.45e-05	0.000812	CcSEcCtD
Lidocaine—CYP2B6—brain—migraine	5.41e-05	0.00454	CbGeAlD
Lidocaine—Dizziness—Timolol—migraine	5.41e-05	0.000805	CcSEcCtD
Lidocaine—CYP3A4—nervous system—migraine	5.35e-05	0.00449	CbGeAlD
Lidocaine—EGFR—Spinal Cord Injury—BDNF—migraine	5.32e-05	0.00194	CbGpPWpGaD
Lidocaine—Feeling abnormal—Topiramate—migraine	5.28e-05	0.000786	CcSEcCtD
Lidocaine—CYP2D6—nervous system—migraine	5.26e-05	0.00442	CbGeAlD
Lidocaine—CYP2A6—NRF2 pathway—SLC6A4—migraine	5.24e-05	0.00191	CbGpPWpGaD
Lidocaine—Vomiting—Timolol—migraine	5.2e-05	0.000774	CcSEcCtD
Lidocaine—Rash—Timolol—migraine	5.15e-05	0.000768	CcSEcCtD
Lidocaine—Dermatitis—Timolol—migraine	5.15e-05	0.000767	CcSEcCtD
Lidocaine—CYP3A4—central nervous system—migraine	5.15e-05	0.00432	CbGeAlD
Lidocaine—Headache—Timolol—migraine	5.12e-05	0.000763	CcSEcCtD
Lidocaine—Urticaria—Topiramate—migraine	5.09e-05	0.000758	CcSEcCtD
Lidocaine—EGFR—Developmental Biology—SCN2A—migraine	5.08e-05	0.00185	CbGpPWpGaD
Lidocaine—CYP2D6—central nervous system—migraine	5.07e-05	0.00425	CbGeAlD
Lidocaine—Dizziness—Gabapentin—migraine	5.03e-05	0.00075	CcSEcCtD
Lidocaine—CYP2D6—cerebellum—migraine	4.95e-05	0.00416	CbGeAlD
Lidocaine—Nausea—Timolol—migraine	4.86e-05	0.000723	CcSEcCtD
Lidocaine—Vomiting—Gabapentin—migraine	4.84e-05	0.000721	CcSEcCtD
Lidocaine—Rash—Gabapentin—migraine	4.8e-05	0.000715	CcSEcCtD
Lidocaine—Dermatitis—Gabapentin—migraine	4.8e-05	0.000714	CcSEcCtD
Lidocaine—Headache—Gabapentin—migraine	4.77e-05	0.00071	CcSEcCtD
Lidocaine—Hypersensitivity—Topiramate—migraine	4.72e-05	0.000703	CcSEcCtD
Lidocaine—EGFR—Developmental Biology—MEF2D—migraine	4.64e-05	0.00169	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	4.62e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	4.62e-05	0.00168	CbGpPWpGaD
Lidocaine—Asthenia—Topiramate—migraine	4.59e-05	0.000684	CcSEcCtD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TGFBR2—migraine	4.54e-05	0.00165	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	4.53e-05	0.00165	CbGpPWpGaD
Lidocaine—Nausea—Gabapentin—migraine	4.52e-05	0.000673	CcSEcCtD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	4.41e-05	0.00161	CbGpPWpGaD
Lidocaine—Dizziness—Topiramate—migraine	4.23e-05	0.000631	CcSEcCtD
Lidocaine—EGFR—MAPK Signaling Pathway—TGFBR2—migraine	4.17e-05	0.00152	CbGpPWpGaD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	4.11e-05	0.0015	CbGpPWpGaD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor—TNF—migraine	4.11e-05	0.0015	CbGpPWpGaD
Lidocaine—Vomiting—Topiramate—migraine	4.07e-05	0.000606	CcSEcCtD
Lidocaine—Rash—Topiramate—migraine	4.04e-05	0.000601	CcSEcCtD
Lidocaine—Dermatitis—Topiramate—migraine	4.03e-05	0.000601	CcSEcCtD
Lidocaine—CYP2D6—brain—migraine	4.02e-05	0.00338	CbGeAlD
Lidocaine—Headache—Topiramate—migraine	4.01e-05	0.000598	CcSEcCtD
Lidocaine—EGFR—MAPK Signaling Pathway—BDNF—migraine	4.01e-05	0.00146	CbGpPWpGaD
Lidocaine—ABCB1—head—migraine	3.99e-05	0.00335	CbGeAlD
Lidocaine—CYP2A6—NRF2 pathway—TGFBR2—migraine	3.95e-05	0.00144	CbGpPWpGaD
Lidocaine—EGFR—ErbB1 downstream signaling—FOS—migraine	3.95e-05	0.00144	CbGpPWpGaD
Lidocaine—Nausea—Topiramate—migraine	3.8e-05	0.000567	CcSEcCtD
Lidocaine—ABCB1—nervous system—migraine	3.79e-05	0.00318	CbGeAlD
Lidocaine—ABCB1—central nervous system—migraine	3.64e-05	0.00306	CbGeAlD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.62e-05	0.00132	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—FOS—migraine	3.6e-05	0.00131	CbGpPWpGaD
Lidocaine—ABCB1—cerebellum—migraine	3.56e-05	0.00299	CbGeAlD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	3.42e-05	0.00124	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	3.38e-05	0.00123	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—ESR1—migraine	3.28e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—ESR1—migraine	3.26e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—RAMP1—migraine	3.21e-05	0.00117	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CALCRL—migraine	3.21e-05	0.00117	CbGpPWpGaD
Lidocaine—ABCB1—brain—migraine	2.89e-05	0.00243	CbGeAlD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	2.89e-05	0.00105	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—FOS—migraine	2.79e-05	0.00102	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	2.78e-05	0.00101	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.71e-05	0.000989	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—FOS—migraine	2.71e-05	0.000988	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	2.6e-05	0.000947	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	2.56e-05	0.000932	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	2.56e-05	0.000932	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CACNA1A—migraine	2.39e-05	0.000871	CbGpPWpGaD
Lidocaine—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	2.36e-05	0.00086	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR1D—migraine	2.33e-05	0.000849	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	2.18e-05	0.000793	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR2B—migraine	2.17e-05	0.000789	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TNF—migraine	1.93e-05	0.000704	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CALCRL—migraine	1.89e-05	0.00069	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—RAMP1—migraine	1.89e-05	0.00069	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	1.83e-05	0.000666	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	1.65e-05	0.000603	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	1.65e-05	0.000603	CbGpPWpGaD
Lidocaine—EGFR—Disease—LRP1—migraine	1.61e-05	0.000586	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CACNA1A—migraine	1.59e-05	0.000579	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—TNF—migraine	1.51e-05	0.000549	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TNF—migraine	1.46e-05	0.000531	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CACNA1A—migraine	1.46e-05	0.000531	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—TNF—migraine	1.44e-05	0.000525	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR1B—migraine	1.41e-05	0.000514	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TNF—migraine	1.39e-05	0.000505	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TNF—migraine	1.39e-05	0.000505	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR1D—migraine	1.38e-05	0.000501	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	1.37e-05	0.000499	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR1A—migraine	1.36e-05	0.000495	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TNF—migraine	1.34e-05	0.00049	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NPS—migraine	1.34e-05	0.000488	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—TAC1—migraine	1.34e-05	0.000488	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TNF—migraine	1.34e-05	0.000487	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.31e-05	0.000479	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR2C—migraine	1.31e-05	0.000478	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR2B—migraine	1.28e-05	0.000466	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—EDNRA—migraine	1.28e-05	0.000465	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CALCA—migraine	1.23e-05	0.000448	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CACNA1A—migraine	1.17e-05	0.000428	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR7—migraine	1.15e-05	0.000419	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CACNA1A—migraine	1.15e-05	0.000418	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—LRP1—migraine	1.13e-05	0.00041	CbGpPWpGaD
Lidocaine—EGFR—Disease—CALCA—migraine	1.04e-05	0.000378	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—FOS—migraine	1.01e-05	0.000368	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CACNA1A—migraine	9.94e-06	0.000362	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TNF—migraine	9.39e-06	0.000342	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CACNA1A—migraine	8.66e-06	0.000316	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOTCH4—migraine	8.64e-06	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFBR2—migraine	8.35e-06	0.000304	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR1B—migraine	8.34e-06	0.000304	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CACNA1A—migraine	8.16e-06	0.000298	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CACNA1A—migraine	8.09e-06	0.000295	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HTR2A—migraine	8.05e-06	0.000293	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR1A—migraine	8.03e-06	0.000292	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—MTHFR—migraine	7.9e-06	0.000288	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TAC1—migraine	7.9e-06	0.000288	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PGR—migraine	7.9e-06	0.000288	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NPS—migraine	7.9e-06	0.000288	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR2C—migraine	7.75e-06	0.000282	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EDNRA—migraine	7.54e-06	0.000275	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOTCH3—migraine	7.35e-06	0.000268	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CALCA—migraine	7.26e-06	0.000264	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CACNA1A—migraine	6.92e-06	0.000252	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR7—migraine	6.79e-06	0.000247	CbGpPWpGaD
Lidocaine—EGFR—Disease—MTHFR—migraine	6.78e-06	0.000247	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	6.64e-06	0.000242	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TNF—migraine	6.15e-06	0.000224	CbGpPWpGaD
Lidocaine—EGFR—Immune System—FOS—migraine	5.88e-06	0.000214	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFBR2—migraine	5.85e-06	0.000213	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CACNA1A—migraine	5.34e-06	0.000195	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—MTHFR—migraine	5.25e-06	0.000191	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—MTHFR—migraine	4.82e-06	0.000175	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HTR2A—migraine	4.75e-06	0.000173	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ESR1—migraine	4.22e-06	0.000154	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MTHFR—migraine	3.89e-06	0.000142	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MTHFR—migraine	3.8e-06	0.000138	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MTHFR—migraine	3.29e-06	0.00012	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MTHFR—migraine	2.87e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MTHFR—migraine	2.7e-06	9.84e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MTHFR—migraine	2.68e-06	9.76e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MTHFR—migraine	2.29e-06	8.34e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MTHFR—migraine	1.77e-06	6.43e-05	CbGpPWpGaD
